FAS and cancer: In conclusion, our study has demonstrated that, in addition to promoting cancer cell invasion and metastasis, Fas signaling enhances drug resistance by upregulating the expression of ABC transporters, especially P-gp, via increasing nuclear β-catenin through ERK1/2 MAPK-GSK3β signaling axis and downregulating miR-145.